Drug Prices

From Sea to Shining Sea: Generic Savings State by State

Safe, reliable generic prescription drugs enable Americans to save money at the pharmacy counter. The government saves big, too, on medicine for seniors and low-income people. In 2017, overall savings came to $265 billion.

AAM’s annual generic drug savings and access report presents the independent findings of IQVIA regarding the savings that our companies bring about, including savings by state.

Generics: Your Prescription for Savings

More FDA-approved generic and biosimilar medicines are available now than ever before. Today, America’s patients are benefitting from significant savings at the pharmacy counter and in lower out-of-pocket costs. But those savings are increasingly at risk due to anti-competitive abuses and misguided policies that block access to lower-cost medicines.

Congress can take meaningful action to lower prescription drug costs for patients who rely on affordable medicines to live healthy lives.

#Rx4Savings

Rich's Story — Savings from Generic Medicines

Rich of Trumbull, Connecticut, counts on generic medicine to stay healthy in his 70's. “There's no question in my mind that generics work," he says. "The doctor explained it was a generic I would be taking, it was no different than the brand and it would be much cheaper. So I said, 'go for it!'” Rich is just one of millions of patients helped every day by the members of the Association of Accessible Medicines, formerly the Generic Pharmaceutical Association. 

Jonnie's Story – Savings from Generic Medicines

Jonnie, 57, of Skiatook, Oklahoma, counts on generic medicine to stay healthy. “I've got the gamut of things that could go wrong as you get older,” she explains. “When you pay for a name brand, it's super expensive. [Do] you know what it's like to have a drug that costs your car payment each month? If it weren't for these generic medications, I don't know where my life would be. I can afford things.” Jonnie is just one of millions of patients helped every day by the members of the Association of Accessible Medicines, formerly the Generic Pharmaceutical Association. 

AAM Statement on FDA Record Generic Approvals

WASHINGTON DC (October 11, 2018) – We appreciate the efforts of the FDA, under the leadership of Commissioner Gottlieb, to lower overall drug prices by seeking to increase the number of generic drug applications on an annual basis. It is important however to recognize that in the current U.S. health care system more generic approvals does not automatically translate into more competition.

Subscribe to Drug Prices

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.